Quick Answer
Esperion Therapeutics, Inc. reported Shares Outstanding of 27.50 million shares for fiscal year 2019.
Esperion Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2019 | 27.50M | +2.5% |
| 2018 | 26.82M | +2.0% |
| 2017 | 26.30M | +16.6% |
| 2016 | 22.56M | +0.2% |
| 2015 | 22.52M | +10.7% |
| 2014 | 20.34M | +32.6% |
| 2013 | 15.34M | +4327.6% |
| 2012 | 346,478 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | 27.86M | +2.5% | +0.4% |
| June 30, 2020 | 27.75M | +2.6% | +0.7% |
| March 31, 2020 | 27.55M | +2.4% | +0.2% |
| December 31, 2019 | 27.50M | +2.5% | +1.2% |
| September 30, 2019 | 27.18M | +1.4% | +0.5% |
| June 30, 2019 | 27.04M | +0.9% | +0.5% |
| March 31, 2019 | 26.91M | +0.6% | +0.3% |
| December 31, 2018 | 26.82M | +2.0% | +0.1% |
- Esperion Therapeutics, Inc. showed an increase of +2.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2012–2019 period, Esperion Therapeutics, Inc.’s shares outstanding has grown by 7836.4% (from 346.5 thousand shares to 27.50 million shares).
- The most recent figure is from Esperion Therapeutics, Inc.’s fiscal year 2020 report (Form 10-K), filed with the SEC on February 23, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: